28
Participants
Start Date
February 6, 2018
Primary Completion Date
March 13, 2018
Study Completion Date
March 13, 2018
Test formulation A
Test formulation: SKF101804 will be available as oral suspension supplied as powder for reconstitution (Off-white to cream coloured powder). Subjects will receive single dose of 5 mL of suspension thus receiving 200 mg dose of cefixime. The suspension is a white to off white viscous suspension with a fruit flavor and odor.
Reference formulation B
Reference formulation will be available as oral suspension supplied as powder for reconstitution (Off-white to cream coloured powder). Subjects will receive single dose of 5 mL of suspension thus receiving 200 mg dose of cefixime. The suspension is a white to off white viscous suspension with a strawberry flavor and odor.
GSK Investigational Site, Bloemfontein
Lead Sponsor
GlaxoSmithKline
INDUSTRY